Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform (Form 8-K) (Calidi Biotherapeutics Inc)

Posted 2025-03-10, Public Technologies Headlines

) Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform SAN DIEGO, Mar. 10, 2025 (GLOBE NEWSWIRE) - Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of... read full story

Ask about this article

Answer for your question of the article will be displayed here ...